Greater Glasgow and Clyde Medicines

Guideline News October 2022

Key Medicine Shortages – November 2022

Key messages

• Refer to available guidance for information on how to alleviate symptoms of the menopause (see links in further information below)
• Refer to the NHSGGC Adult Medicines Formulary for preferred hormone replacement therapy (HRT) options
• If ‘off-label’ testosterone is being considered for low sexual desire (when HRT alone is not effective), refer to NICE and British Menopause Society (BMS) guidance and the NHSGGC Unlicensed Medicines Policy

MHRA Drug Safety Update October 2022

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Guideline News September 2022

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Guideline News for July 2022

• Metronidazole has excellent oral bioavailability reaching 95-100%.

• NHSGGC Adult Infection Management Guidelines were updated to include the option of oral metronidazole in the management of intra-abdominal sepsis (IAS) and diabetic foot infection.